MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopa-responsive dystonia(DRD)"

  • MDS Virtual Congress 2020

    A New Complex dystonic presentation of a rare gene – CACNA1B and its response to Levodopa

    S. Medarametla, B. Nataraju, S. Kodapala, S. Raju (Bangalore, India)

    Objective: We report a case of complex dystonia with the rare gene- CACNA1B. Background: CACNA1B gene has previously been reported as the cause of myoclonus-…
  • MDS Virtual Congress 2020

    Late-Onset Dopa-Responsive Dystonia: A Case Report

    O. Oztop Cakmak, S. Ertan, S. Tekgul, N. Basak (Istanbul, Turkey)

    Objective: To present a rare cause of treatable dystonia with onset during adulthood. Background: L-Dopa-responsive dystonia is an inherited disorder characterized by early-onset dystonia affecting…
  • 2019 International Congress

    Different clinical entities of Segawa syndrome within a family

    J. Sarangerel (Ulaanbaatar, Mongolia)

    Objective: We report two cases of mother and daughter, both having different expressions of dystonic movements. Background: One of rare dystonic disorders is Segawa syndrome…
  • 2019 International Congress

    Spectrum of parkinsonian phenotypes associated with GCH1 mutation.

    D. Al-Shorafat, A. Shetty, D. Munoz, A. Fasano, A. Lang (Toronto, ON, Canada)

    Objective: To describe the heterogeneity of parkinsonism in patients with GCH1 mutations. Background: Dopa-responsive dystonia (DRD) is an inherited disorder that responds dramatically to levodopa…
  • 2019 International Congress

    PRKN Positive Parkinson’s Disease Masked as Dopa-Responsive Dystonia

    S. Chiu, A. Elkouzi, L. Almeida (Gainesville, FL, USA)

    Objective: To report a Parkinson’s disease (PD) patient with PRKN mutation initially diagnosed with dopa-responsive dystonia (DRD), unmasked after developing signs of parkinsonian disease progression.…
  • 2019 International Congress

    Clinical and genetic characteristics of a new mutation causing Segawa´s disease in a Spanish kindred

    J. Hernández-Vara, S. Lucas (Barcelona, Spain)

    Objective: To describe the clinical phenotype and genetic characteristics of a novel mutation causing Segawa´s disease in a Spanish family. Background: Dopa-Responsive Dystonia (DRD) is…
  • 2019 International Congress

    Pregnancy and Delivery Complications in Women with Inherited Isolated Dystonia

    M. San Luciano, V. Shanker, S. Bressman, D. Raymond, R. Saunders-Pullman (San Francisco, CA, USA)

    Objective: To determine whether female mutation carriers of inherited dopa-responsive (DRD) and DYT/TOR1A genes had higher pregnancy and delivery complications than non-carriers Background: Women with…
  • 2019 International Congress

    Atypical presentation of Dopa-responsive dystonia- late onset with severe swallowing difficulty

    C. Zhao, L. Li, H. Li, J. Zhang (Jinan, China)

    Objective: To learn about atypical presentation of Dopa-responsive dystonia (DRD) and give correct diagnose in time. Background: DRD compasses a group of clinically and genetically…
  • 2018 International Congress

    Neuropathology of dopa-responsive dystonia due to Tyrosine hydroxylase deficiency

    S. Schreglmann, Z. Jaunmuktane, H. Jung, C. Strand, J. Holton, K. Bhatia (London, United Kingdom)

    Objective: To describe detailed neuropathology findings from an autopsy case of dopa-responsive dystonia (DRD) with genetically confirmed tyrosine hydroxylase deficiency (THD). Background: DRD comprises a…
  • 2018 International Congress

    Molecular mechanisms of GCH1-associated Parkinson’s disease

    J. Terbeek, W. Vandenberghe (Leuven, Belgium)

    Objective: To unravel the molecular mechanisms by which loss of GCH1 function enhances the risk of Parkinson´s disease (PD). Background: Loss-of-function mutations in GCH1 are…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley